Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback